These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23228630)

  • 21. Preoperative localization of hepatomas by sonography with microbubbles of carbon dioxide.
    Kubo S; Kinoshita H; Hirohashi K; Tsukamoto T; Shuto T
    AJR Am J Roentgenol; 1994 Dec; 163(6):1405-6. PubMed ID: 7992737
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic hepatitis C virus infection: detection of hepatocellular carcinoma by means of contrast-enhanced color Doppler liver sonography.
    Zardi EM; Toccaceli F; Russo V; Uwechie V; Sereno S; Laghi V
    Am J Gastroenterol; 2000 Oct; 95(10):2996-8. PubMed ID: 11051396
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of Suspected Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound.
    Squires JH; Bill A; Thieret J; Squires JE
    J Pediatr; 2017 Mar; 182():398-398.e1. PubMed ID: 28063693
    [No Abstract]   [Full Text] [Related]  

  • 24. [The contrast enhanced ultrasonography of hepatic vessels].
    Lu MD; Liang LJ
    Zhonghua Wai Ke Za Zhi; 1994 Apr; 32(4):255-6. PubMed ID: 7842935
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatocellular carcinoma: harmonic ultrasound and contrast agent.
    Kim TK; Kim AY; Choi BI
    Abdom Imaging; 2002; 27(2):129-38. PubMed ID: 11847572
    [No Abstract]   [Full Text] [Related]  

  • 26. [Super para magnetic iron oxide--Feridex].
    Ohtomo K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():319-22. PubMed ID: 11761965
    [No Abstract]   [Full Text] [Related]  

  • 27. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
    Hiraoka A; Hiasa Y; Onji M; Michitaka K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intravenous ultrasound contrast agent, Levovist].
    Kudo M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():306-13. PubMed ID: 11761963
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocellular carcinoma.
    Ozsarlak O; De Schepper AM; d'Archambeau O; Michielsen P; Pelckmans PA
    J Belge Radiol; 1997 Dec; 80(6):305. PubMed ID: 9479903
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contrast medium-supported sonography of the liver--a challenge to German radiology].
    Albrecht T
    Rofo; 2003 Jul; 175(7):889-91. PubMed ID: 12847642
    [No Abstract]   [Full Text] [Related]  

  • 31. Contrast-enhanced ultrasonography during liver surgery.
    Torzilli G; Del Fabbro D; Olivari N; Calliada F; Montorsi M; Makuuchi M
    Br J Surg; 2004 Sep; 91(9):1165-7. PubMed ID: 15449268
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation.
    Koda M; Mandai M; Matono T; Sugihara T; Nagahara T; Ueki M; Ohyama K; Hosho K; Murawaki Y
    Clin Imaging; 2010; 34(1):60-4. PubMed ID: 20122522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dual phase CT--better diagnostic accuracy for liver neoplasms].
    Rofo; 2005 Oct; 177(10):1347. PubMed ID: 16170702
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic algorithm of hepatocellular carcinoma on cirrhosis: CEUS or no CEUS, that is the problem.
    Giorgio A
    Dig Liver Dis; 2011 Jun; 43(6):499. PubMed ID: 21324763
    [No Abstract]   [Full Text] [Related]  

  • 35. Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma.
    Hotta N; Tagaya T; Maeno T; Ishikawa T; Okumura A; Fukuzawa Y; Kakumu S
    Hepatogastroenterology; 2003; 50(54):1867-71. PubMed ID: 14696421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance.
    Giorgio A; Ferraioli G; Tarantino L; de Stefano G; Scala V; Scarano F; Coppola C; Del Viscovo L
    AJR Am J Roentgenol; 2004 Nov; 183(5):1319-26. PubMed ID: 15505297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of hepatocarcinoma treated with percutaneous ablation].
    Lencioni R; Paolicchi A; Armillotta N; Cioni D; Donati F; Bartolozzi C
    Radiol Med; 1998 May; 95(5 Suppl 1):53-8. PubMed ID: 9687904
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatocellular carcinoma presenting as a wandering abdominal lump with atypical CEUS.
    Xu HS; Li SY; Liang X; Shou JD; Xu K; He YT
    Ultraschall Med; 2013 Aug; 34(4):388-90. PubMed ID: 23929380
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatocellular carcinoma in adenomatous hyperplasia: detection with contrast-enhanced US with carbon dioxide microbubbles.
    Nomura Y; Matsuda Y; Yabuuchi I; Nishioka M; Tarui S
    Radiology; 1993 May; 187(2):353-6. PubMed ID: 8386389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma.
    Andreana L; Kudo M; Hatanaka K; Chung H; Minami Y; Maekawa K; Ruggiero G
    Oncology; 2010 Jul; 78 Suppl 1():68-77. PubMed ID: 20616587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.